Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate

Journal of Cellular Biochemistry

Volumn 75, Issue 1, 1999, Pages 1-12

  Liang, Yu Chih ^a   Lin Shiau, Shoei Yn ^a   Chen, Chieh Fu ^b   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

( ) epigallocatechin 3 gallate; Cell cycle; Cyclin; Cyclin dependent kinase; Retinoblastoma protein

Indexed keywords

CYCLIN DEPENDENT KINASE; EPIGALLOCATECHIN GALLATE; PROTEIN P27;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TEACHING HOSPITAL;

CATECHIN; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033213758     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19991001)75:1<1::AID-JCB1>3.0.CO;2-N     Document Type: Article

References (42)

1. Anonymous. 1996. Clinical development plan: tea extracts. Green tea polyphenols, Epigallocatechin gallate. J Cell Biochem 26S:236-257.
2. Aprelikova O, Xiong Y, Liu ET. 1995. Both p16 and p21 families of cyclin-dependent kinase (Cdk) inhibitors block the phosphorylation of cyclin-dependent kinases by the cdk-activatingkinase. J Biol Chem 270:18195-18197.
3. Botz J. 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol 16:3401-3409.
4. Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D. 1988. p53 expression in breast cancer. Int J Cancer 41:178-183.
5. +2 ion and cellular p53 protein by curcumin in colorectal carcinoma cells. Mol Carcinogen 17:224-234.
6. Chernora OB, Chernov MV, Agarwal ML, Taylor WR, Stark GR. 1995. The role of p53 in regulating genomic stability when DNA synthesis are inhibited. Trends Biochem Sci 20:431-434.
7. El-Deiry WS. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174.
8. Hensey CE, Hong F, Durfee T, Qian Y-W, Lee Eva Y-HP, Lee W-H. 1994. Identification of discrete structural domains in the retinoblastoma protein. J Biol Chem 269:1380-1387.
9. Hirayama T. 1986. A large scale cohort study on cancer risks by diet - with special reference to the risk reducing effects of green-yellow vegetable consumption. In: Diet, nutrition and cancer. Hayashi Y, Nagao M, Sugimura T, Takayama S, Tomatis L, Wattenbery LW, Wogan GN, editors. Tokyo: Japan Scientific Societies Press. p 41-53.
10. Ho CT, Chen Q, Shi H, Zhang KQ, Rosen RT. 1992. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 21:520-525.
11. Katiyar S, Kagarwal R, Zain MT, Mukntar H. 1993. Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 14:849-855.
12. Kaur G, Stetler-Stevenson M, Sebers S, Worland P, Sedlacek H, Myers C, Czech J, Naik R, Sausville E. 1992. Growth inhibition with reversible cell cycle arrest of carcinoma cells by the flavone L86-8275. J Natl Cancer Inst 84:1736-1740.
13. Kawakami K, Futami H, Takahara J, Yamaguchi K. 1996. UCN-01, 7-hydroxylstaurosporine, inhibit kinase activity of cyclin-dependent kinase and reduces the phosphorylation of the retinoblastoma susceptibility gene product in an A549 human lung carcinoma cell line. Biochem Biophys Res Commun 219:778-783.
14. Lepley DM, Li B, Birt DF, Felling JC. 1996. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17:2367-2375.
15. Liang Y-C, Lin-Shiau S-Y, Chen C-F, Lin J-K. 1997. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermal carcinoma cells. J Cell Biochem 67:55-65.
16. Lin Y-L, Lin J-K. 1997. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lippolysaccharide-induced activity of transcription factor nuclear factor-KB. Mol Pharm 52:465-472.
17. Lin Y-L, Juan I-M, Chen Y-L, Liang Y-C, Lin J-K. 1996. Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with antiproliferative actions in fibroblast cells. J Agri Food Chem 44:1387-1394.
18. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. 1993. Genistein arrests cell cycle progression at G2-M. Cancer Res 53:1328-1331.
19. Morgan DO. 1995. Principles of CDK regulation. Nature 374:131-134.
20. Nakane H, Dno K. 1990. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry 29:2841-2845.
21. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-98.
22. Nonaka GI, Kawahara O, Nishioka I. 1983. Tannins and related compounds XV. A new class of dimeric flavan-3-ol gallates, theasinensins A and B, and proanthocyanidin gallates from green tea leaf. Chem Pharm Bull 31:3906-3914.
23. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. 1997. Mechanisms of growth inhibition human lung cancer cell line, PC-9, by Tea polyphenols. Jpn J Cancer Res 88:639-643.
24. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledege SJ. 1995. p53-independent expression of p21cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027.
25. Pedrali-Noy G, Spadari S, Miller-Faures A, Miller AO, Kruppa J, Koch G. 1980. Synchronization of HeLa cell cultures by inhibition of DNA polymerase-α with aphidicolin. Nucleic Acids Res 8:377-387.
26. Sato F, Matsukawa Y, Matsumoto K, Nishino H, Sakai T. 1994. Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells. Biochem Biophys Res Commun 204:578-584.
27. Sedlacek HH, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, Parker B, Carlson B, Smith A, Senderowicz A, Sausville E. 1996. Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. Int J Oncol 9:1143-1168.
28. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
29. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
30. Shi ST, Wang ZT, Smith TJ, Hong JY, Chen WF, Ho CT, Yang CS. 1994. In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by x-ray. Cancer Res 54:4641-4647.
31. Spinozzi F, Pagliacci MC, Migliorati G, Moraca R, Grignani F, Riccardi C, Nicoletti I. 1994. The natural tyrosine kinase inhibitor genistein products cell cycle arrest and apoptosis in jurkat T-leukemia cells. Leuk Res 18:431-439.
32. Stoner GD, Mukhtar H. 1995. Polyphenols as cancer chemopreventive agents. J Cell Biochem 22S:169-180.
33. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. 1992. Effects of genistein on the growth and cell cycle progression of natural human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res 52:6200-6208.
34. Wang Q, Worlan PJ, Clark JL, Carlson BA, Sausville EA. 1995. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinase 1 and 2. Cell Growth Diff 6:927-936.
35. Wei H, Tye L, Bresnick E, Birt DF. 1990. Inhibitory effect of apigenin, a plant flavonoids, an epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50:449-502.
36. Wei Y, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. 1994. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54:4952-4957.
37. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
38. Xiong Y, Zhang H, Beach D. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
39. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H 1995. Incorporation of 5-bromo-2′-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res 5:2081-2084.
40. Yang CS, Wang ZY. 1993. Tea and cancer. J Natl Cancer Inst 85:1038-1049.
41. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H, Aoike A. 1990. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260:10-13.
42. Zieve GW, Turnbull D, Mulling JM, McIntoch JR. 1980. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp Cell Res 126: 397-405.